文献速递药物不良反应与药物警戒

利用医院数据库识别药物不良反应:法国9家综合医院为期2年的多中心研究

Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitals.
PubMed 文献 · Br J Clin Pharmacol · 2020-06-18

该研究在法国9家综合医院2014年7月至2016年6月期间,采用捕获-再捕获方法结合法国医疗行政数据库(PMSI)与法国药物警戒数据库(FPVDB)两个来源估计药物不良反应(ADR)实际数量。结果PMSI中56.9%的住院与ADR相关(628/1104),FPVDB保留115例,两库共同43例,估计ADR总数为1657例(95%CI:1273至2040)。结论认为PMSI可作为估计法国医院ADR实际数量的补充工具。

要点

  • PMSI中56.9%住院与ADR相关,FPVDB保留115例,两库共同43例。
  • 两库最常见ADR均为皮肤类(33.1%和19.1%)和肾脏类(25.2%和11.6%)。
  • 捕获-再捕获法估计ADR总数为1657例(95%CI:1273至2040)。

核心结论

  • 使用PMSI可作为估计法国医院ADR实际数量的补充工具。
  • 涉及第三数据源的模型可在应用捕获-再捕获法前检验PMSI与FPVDB两来源的独立性。

研究设计与样本

  • 研究于2014年7月1日至2016年6月30日在法国9家综合医院开展。
  • 采用捕获-再捕获方法结合PMSI与FPVDB两个来源,并通过第三数据源检验其独立性。
  • 从PMSI中分析所有包含与ADR相关的第10版国际疾病分类编码的出院小结,编码选择基于既往研究结果。
  • 纳入FPVDB中自发报告且对应上述编码的所有ADR。

主要发现

  • PMSI中56.9%的住院与ADR相关(628/1104)。
  • FPVDB中保留115例ADR。
  • 两数据库共同报告43例ADR。
  • PMSI中最常见ADR为皮肤类(33.1%)和肾脏类(25.2%)。
  • FPVDB中最常见ADR为皮肤类(19.1%)和肾脏类(11.6%)。

临床怎么用

  • 临床药学智能体可参考PMSI编码筛选出院小结中的ADR相关住院,补充自发报告漏报。
  • 关注皮肤和肾脏相关ADR,以及抗感染药和抗肿瘤药等常见可疑药物类别。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To estimate the actual number of adverse drug reactions (ADRs), we used the French medical administrative database (PMSI) in addition to ADRs spontaneously reported in the French Pharmacovigilance Database (FPVDB). METHODS: Capture-recapture method was applied to these 2 sources (PMSI and FPVDB), checking their independence via a third data source. The study ran from 1 July 2014 to 30 June 2016 in 9 French general hospitals. From PMSI, all discharge summaries including a selection of 10th International Classification of Diseases codes related to ADRs were analysed. This selection was based on the results of a previous study. All ADRs corresponding to these codes, spontaneously reported in the FPVDB, were included. RESULTS: In PMSI, 56.9% of hospital stays were related to an ADR (628 out of 1104). In the FPVDB, we retained 115 cases. A total of 43 ADRs were common to the 2 databases. In both sources, the most frequently reported ADRs were cutaneous (33.1 and 19.1%) and renal (25.2% and 11.6%). The most frequently suspected drugs were anti-infectives in PMSI (31.1%) and antineoplastic drugs in the FPVDB (30.4%). Using the capture-recapture method, the estimated number of ADRs was 1657 [95% CI: 1273 to 2040]. CONCLUSION: The use of the PMSI could constitute an additional tool for the estimation of the actual number of ADRs in French hospitals. A model involving a third data source enabled the independence of the 2 sources (PMSI and FPVDB) to be checked before applying the capture-recapture method.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Osmont MN, Degremont A, Jantzem H, et al. Hospital databases for the identification of adverse drug reactions: A 2-year multicentre study in 9 French general hospitals. Br J Clin Pharmacol. 2020. PMID: 32484575. doi:10.1111/bcp.14405

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。